Disc Medicine prices $250 million upsized stock offering
PositiveFinancial Markets

Disc Medicine has successfully upsized its stock offering to $250 million, a move that reflects strong investor confidence and positions the company for future growth. This significant capital raise will enable Disc Medicine to advance its innovative therapies and expand its market presence, which is crucial in the competitive biotech landscape.
— Curated by the World Pulse Now AI Editorial System